The Leadership Changes at InnovaCare that has Incorporated Distinguished leader like Penelope Kokkinides
Posted on : 02-27-2017 By : Samantha Pointer
InnovaCare Health Solutions Inc. is a leading provider of managed healthcare services in North America. InnovaCare is focused on providing quality healthcare services through establishing cost-effective and sustainable programs that are equipped with current state-of-the-art technology. Their managed health care services include physicians care practice and two Medicare plans; PMC Medicare Choice and MMM Healthcare. They provide these services to about 200,000 clients through a network of 7,500 service providers. Also, InnovaCare provided two Medicaid programs to its customers through Puerto Rico Government Health Plan (GHP). InnovaCare is headed by…
Read More
0 Comments
Eric Lefkofsky Began His Adult Life With A Unique Carpet Business
Posted on : 11-15-2016 By : Samantha Pointer
Many people have a lot of unique stories as to how they got their start in business. Eric Lefkofsky is no different, but his journey might be more strange than any other story heard in the past. Eric's journey began just before he started college. He went through a bad breakup and needed to do something to keep his mind off the situation. However, he did not want to take traditional approaches and go through therapy or anything like that. Eric wanted to make money and thereby keep his mind…
Read More
0 Comments
What You Should Know About Clay Siegall and Seattle Genetics Biotechnology Company
Posted on : 10-12-2016 By : Samantha Pointer
In the past few years, Seattle Genetics has been one of the most talked about biotechnology companies in Bothell. This is attributed to the exponential growth sparked by large financing rounds. The latest announcement indicates that they plan to increase public stock offering from $480 to $522. To achieve this, President and CEO Clay Siegall is keen to explore the over-allotment option. An overwhelming interest from investors is another factor that has contributed to the company’s growth. Investors are particularly keen to fund the growth of both human resources and…
Read More
0 Comments
The Technology that is changing the Lives of Many: Seattle Genetics
Posted on : 07-26-2016 By : Samantha Pointer
The Seattle Genetics is significantly influencing the lives of many people. Giving hope to the many families who don’t give up hope of their loved ones being well again. The team of dedicated scientists has positively impacted the health of their patients who are always on the forefront of every research they conduct. Whatever they do, they do it with the patients in mind and the desire to elongate their lives, so that they can continue being productive in the society. The biotech company uses miRNAs. The miRNAs code with the human genome and then use them as natural regulators of the global gene expression. Since each of the miRNAs regulates many more different genes; tens of thousands, they may act as the master switch, and they effectively affect the functioning and processes of multiple cellular pathways. The multiple miRNAs in their portfolio have applications in Oncology and other diseases. The oncology-directed miRNAs include the miR-34 and let-7, cancer suppressors that have been effective in blocking tumor growth. The company, due to its impact on human life and more so their health has received funding from many private investors through the emerging technology fund and from the Cancer Prevention and Research Institute of Texas. The president and chief executive officer Dr. Clay B. Siegall was appointed the chief director of the Seattle Genetics; being one of its co-founders, and a renowned doctor, he sure had the knowledge of all the company does. He has not only contributed in the leaders but also in the development of the technology and in impacting the lives of the people of Texas. Through his leadership, the Seattle Genetics has acquired multiple licenses for their technology (ADC), e.g. the Genentech, AbbVie, GlaxoSmithKline and Pfizer that generate more than $ 300 million for the company. He has led the company in capital-raising activities through the public and private financing. Not forgetting his impact on patients’ lives which is based on his innovativeness, vigorous research, drug development practices, but more so his passion for helping patients. His efforts have led the company through his leadership in the development of antibody-drug conjugates ADCs for cancer treatment. Learn More: https://twitter.com/seattlegenetics http://people.equilar.com/bio/clay-siegall-seattle-genetics/salary/42318#.V3_Y2Y6RKGg
Read More
0 Comments